In vivo detection of clinically non-apparent ocular surface inflammation in patients with meibomian gland dysfunction-associated refractory dry eye symptoms: A pilot study

Eye (Basingstoke)

Volumn 29, Issue 8, 2015, Pages 1099-1110

  Qazi, Y ^a   Kheirkhah, A ^a   Blackie, C ^b   Cruzat, A ^a   Trinidad, M ^a   Williams, C ^a   Korb, D R ^b   Hamrah, P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Korb Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CORTICOSTEROID; DOXYCYCLINE;

ADULT; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONFOCAL MICROSCOPY; CONFOCAL SCANNING LASER OPHTHALMOSCOPE; CONJUNCTIVA EPITHELIUM; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORNEA CELL; DENDRITIC CELL; DISEASE ASSOCIATION; DRY EYE; EYE INFLAMMATION; EYE PHOTOGRAPHY; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; IN VIVO STUDY; LACRIMATION; MALE; MEIBOMIAN GLAND DYSFUNCTION; OBSERVATIONAL STUDY; OCULAR SURFACE DISEASE; PILOT STUDY; REFRACTORY DRY EYE; RETROSPECTIVE STUDY; SLIT LAMP; SYSTEMIC THERAPY; TOPICAL TREATMENT; AGED; CASE CONTROL STUDY; CORNEAL EDEMA; DRY EYE SYNDROMES; LACRIMAL FLUID; MEIBOMIAN GLAND; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION (PROCESS);

ADULT; AGED; CASE-CONTROL STUDIES; CORNEAL EDEMA; DRY EYE SYNDROMES; FEMALE; HUMANS; MALE; MEIBOMIAN GLANDS; MIDDLE AGED; PILOT PROJECTS; RETROSPECTIVE STUDIES; TEARS;

EID: 84939188813     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2015.103     Document Type: Article

References (52)

1. Viso E, Gude F, Rodriguez-Ares MT. The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain. Cornea 2011; 30(1): 1-6.
2. Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf 2004; 2(2): 149-165.
3. Rege A, Kulkarni V, Puthran N, Khandgave T. A clinical study of subtype-based prevalence of dry eye. J Clin Diagn Res 2013; 7(10): 2207-2210.
4. Nichols KK. The international workshop on meibomian gland dysfunction: introduction. Invest Ophthalmol Vis Sci 2011; 52(4): 1917-1921.
5. Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci 2011; 52(4): 1994-2005.
6. Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011; 52(4): 2050-2064.
7. Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 2011; 52(4): 1938-1978.
8. Maskin SL. Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction. Cornea 2010; 29(10): 1145-1152.
9. Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea 2012; 31 (4): 396-404.
10. Greiner JV. Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment. Clin Experiment Ophthalmol 2013; 41(6): 524-530.
11. Cuevas M, Gonzalez-Garcia MJ, Castellanos E, Quispaya R, Parra Pde L, Fernandez I et al. Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD). Curr Eye Res 2012; 37(10): 855-863.
12. Johnson ME. The association between symptoms of discomfort and signs in dry eye. Ocul Surf 2009; 7(4): 199-211.
13. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004; 23(8): 762-770.
14. Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol 2012; 92(2): 161-166.
15. Baum JL. Evaporative dry eye-signs and symptoms don't mesh-and other thoughts. Ophthalmology 2010; 117(7): 1285-1286.
16. Ibrahim OM, Matsumoto Y, Dogru M, Adan ES, Wakamatsu TH, Goto T et al. The efficacy, sensitivity, and specificity of in vivo laser confocal microscopy in the diagnosis of meibomian gland dysfunction. Ophthalmology 2010; 117(4): 665-672.
17. Dougherty BE, Nichols JJ, Nichols KK. Rasch analysis of the Ocular Surface Disease Index (OSDI). Invest Ophthalmol Vis Sci 2011; 52(12): 8630-8635.
18. Ozcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm 2007; 15(5): 389-393.
19. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000; 118(5): 615-621.
20. Ngo W, Situ P, Keir N, Korb D, Blackie C, Simpson T. Psychometric properties and validation of the Standard Patient Evaluation of Eye Dryness questionnaire. Cornea 2013; 32(9): 1204-1210.
21. Hamrah P, Sahin A, Dastjerdi MH, Shahatit BM, Bayhan HA, Dana R et al. Cellular changes of the corneal epithelium and stroma in herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology 2012; 119(9): 1791-1797.
22. Matsumoto Y, Shigeno Y, Sato EA, Ibrahim OM, Saiki M, Negishi K et al. The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy. Graefes Arch Clin Exp Ophthalmol 2009; 247(6): 821-829.
23. Wei A, Hong J, Sun X, Xu J. Evaluation of age-related changes in human palpebral conjunctiva and meibomian glands by in vivo confocal microscopy. Cornea 2011; 30(9): 1007-1012.
24. Villani E, Beretta S, Galimberti D, Viola F, Ratiglia R. In vivo confocal microscopy of conjunctival roundish bright objects: young, older, and Sjogren subjects. Invest Ophthalmol Vis Sci 2011; 52(7): 4829-4832.
25. Matsumoto Y, Sato EA, Ibrahim OM, Dogru M, Tsubota K. The application of in vivo laser confocal microscopy to the diagnosis and evaluation of meibomian gland dysfunction. Mol Vis 2008; 14: 1263-1271.
26. Cruzat A, Witkin D, Baniasadi N, Zheng L, Ciolino JB, Jurkunas UV et al. Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis. Invest Ophthalmol Vis Sci 2011; 52(8): 5136-5143.
27. Kobayashi A, Yoshita T, Sugiyama K. In vivo findings of the bulbar/palpebral conjunctiva and presumed meibomian glands by laser scanning confocal microscopy. Cornea 2005; 24(8): 985-988.
28. Villani E, Beretta S, De Capitani M, Galimberti D, Viola F, Ratiglia R. In vivo confocal microscopy of meibomian glands in Sjogren's syndrome. Invest Ophthalmol Vis Sci 2011; 52(2): 933-939.
29. Mastropasqua L, Nubile M, Lanzini M, Carpineto P, Ciancaglini M, Pannellini T et al. Epithelial dendritic cell distribution in normal and inflamed human cornea: in vivo confocal microscopy study. Am J Ophthalmol 2006; 142(5): 736-744.
30. Erdelyi B, Kraak R, Zhivov A, Guthoff R, Nemeth J. In vivo confocal laser scanning microscopy of the cornea in dry eye. Graefes Arch Clin Exp Ophthalmol 2007; 245(1): 39-44.
31. Mayer WJ, Mackert MJ, Kranebitter N, Messmer EM, Gruterich M, Kampik A et al. Distribution of antigen presenting cells in the human cornea: correlation of in vivo confocal microscopy and immunohistochemistry in different pathologic entities. Curr Eye Res 2012; 37(11): 1012-1018.
32. Kojima T, Matsumoto Y, Dogru M, Tsubota K. The application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease. Mol Vis 2010; 16: 2457-2464.
33. Kojima T, Matsumoto Y, Ibrahim OM, Sato EA, Dogru M, Tsubota K. In vivo evaluation of superior limbic keratoconjunctivitis using laser scanning confocal microscopy and conjunctival impression cytology. Invest Ophthalmol Vis Sci 2010; 51(8): 3986-3992.
34. Rolando M, Brezzo V, Calabria G. Ocular surface changes induced by repeated impression cytology. Adv Exp Med Biol 1994; 350: 249-254.
35. Efron N, Al-Dossari M, Pritchard N. In vivo confocal microscopy of the palpebral conjunctiva and tarsal plate. Optom Vis Sci 2009; 86(11): E1303-E1308.
36. Kashkouli MB, Fazel AJ, Kiavash V, Nojomi M, Ghiasian L. Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double masked open label clinical trial. Br J Ophthalmol 2014; 99(2): 199-204.
37. Foulks GN, Borchman D, Yappert M, Kim SH, McKay JW. Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations. Cornea 2010; 29(7): 781-788.
38. Igami TZ, Holzchuh R, Osaki TH, Santo RM, Kara-Jose N, Hida RY. Oral azithromycin for treatment of posterior blepharitis. Cornea 2011; 30(10): 1145-1149.
39. Yoo SE, Lee DC, Chang MH. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol 2005; 19(4): 258-263.
40. Foulks GN, Borchman D, Yappert M, Kakar S. Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study. Cornea 2013; 32(1): 44-53.
41. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004; 45(12): 4293-4301.
42. Simons E, Smith PG. Sensory and autonomic innervation of the rat eyelid: neuronal origins and peptide phenotypes. J Chem Neuroanat 1994; 7(1-2): 35-47.
43. van der Werf F, Baljet B, Prins M, Ruskell GL, Otto JA. Innervation of the palpebral conjunctiva and the superior tarsal muscle in the cynomolgous monkey: a etrograde fluorescent tracing study. J Anat 1996; 189(Pt 2): 285-292.
44. Chung CW, Tigges M, Stone RA. Peptidergic innervation of the primate meibomian gland. Invest Ophthalmol Vis Sci 1996; 37(1): 238-245.
45. Seifert P, Spitznas M. Immunocytochemical and ultrastructural evaluation of the distribution of nervous tissue and neuropeptides in the meibomian gland. Graefes Arch Clin Exp Ophthalmol 1996; 234(10): 648-656.
46. Seifert P, Spitznas M. Vasoactive intestinal polypeptide (VIP) innervation of the human eyelid glands. Exp Eye Res 1999; 68 (6): 685-692.
47. Kirch W, Horneber M, Tamm ER. Characterization of Meibomian gland innervation in the cynomolgus monkey (Macaca fascicularis). Anat Embryol (Berl) 1996; 193(4): 365-375.
48. Kenney MJ, Ganta CK. Autonomic nervous system and immune system interactions. Compr Physiol 2014; 4(3): 1177-1200.
49. Hartschuh W, Weihe E, Reinecke M. Peptidergic (neurotensin, VIP, substance P) nerve fibres in the skin. Immunohistochemical evidence of an involvement of neuropeptides in nociception, pruritus and inflammation. Br J Dermatol 1983; 109(Suppl 25)): 14-17.
50. Obata H. Anatomy and histopathology of human meibomian gland. Cornea 2002; 21(7 Suppl): S70-S74.
51. Straatsma BR. Cystic degeneration of the meibomian glands. AMA Arch Ophthalmol 1959; 61(6): 918-927.
52. Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 2011; 52(4): 2006-2049.